Insulin therapy in children and adolescents with diabetes

Diabetes Research and Clinical Practice

Volumn 93, Issue SUPPL. 1, 2011, Pages

  Galli Tsinopoulou, Assimina ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

Adolescents; Children; Diabetes mellitus; Insulin therapy

Indexed keywords

ANTIDIABETIC AGENT; BIPHASIC INSULIN; INSULIN; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN GLULISINE; INSULIN LISPRO; ISOPHANE INSULIN; PIG INSULIN;

ADOLESCENT; ARTICLE; BURNING SENSATION; CHILD; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG DOSE REGIMEN; DRUG EFFECT; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN TREATMENT; PATIENT EDUCATION; PH; QUALITY OF LIFE; SIDE EFFECT; SYRINGE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS;

EID: 84860421117     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/S0168-8227(11)70026-2     Document Type: Article

References (27)

1. Banting FG, Best CH, Collip JB, Campell WR, Fletcher AA Pancreatic extracts in the treatment of diabetes mellitus. Can Med Assoc J 1922, 12:141-146.
2. Stylianou C, Kelnar C The introduction of successful treatment of diabetes mellitus with insulin. The James Lind Library 2008 http://www.jameslindlibrary.org.
3. d'Annunzio G, Cortona L, Vitali L, Pessino P, Lorini R Final height attainment in girls and boys with insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1994, 24:187-193.
4. Elamin A, Hussein O, Tuvemo T Growth, puberty, and final height in children with Type 1 diabetes. J Diabetes Complications 2006, 20:252-256.
5. Roberts L, Jones TW, Fournier PA Exercise training and glycemic control in adolescents with poorly controlled type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2002, 15(5):621-627.
6. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001, 139:804-812.
7. Shichiri M, Kishikawa H, Ohkubo Y, Wake N Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 2000, 23:B21-B29.
8. The Diabetes Control and Complication Trial research group The effect of intensive treatment of diabetes on the development of progression of long-term complications in insulin dependent diabetes mellitus. N EngJ Med 1993, 329:977-986.
9. Crotty S, Reynolds SL The new insulins. Pediatr Emerg Care 2007, 23:903-905.
10. Bangstad H-J, Danne T, Deeb LC, Jarosz-Chobot P, Urakami T, Hanas R Insulin treatment in children and adolescents with diabetes. Pediatr Diabetes 2009, 10:82-99.
11. Hirsch I Insulin analogs. New Engl J Med 2005, 352:174-183.
12. American Diabetes Association Standards of Medical Care in Diabetes. Diabetes Care 2007, 30:S4-36.
13. Danne T, Mortensen HB, Hougaard P, Lynggaard H, Aanstoot HJ, Chiarelli F, et al. Persistent differences among centers over 3 years in glycemic control and hypoglycaemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidore Study Group. Diabetes Care 2001, 24:1342-1347.
14. Danne T, Aman J, Schober E, Deiss D, Jacobsen JL, Friberg HH, et al. A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care 2003, 26:2359-2364.
15. Hamann A, Matthaei S, Rosak C, Silvestre L A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care 2003, 26:1738-1744.
16. Dixon B, Peter Chase H, Burdick J, et al. Use of insulin glargine in children under age 6 with type 1 diabetes. Pediatr Diabetes 2005, 6:150-154.
17. Jackson A, Ternand C, Brunzell C, Kleinschmidt T, Dew D, Milla C, et al. Insulin glargine improves hemoglobin Ale in children and adolescents with poorly controlled type 1 diabetes. Pediatr Diabetes 2003, 4:64-69.
18. Brunetti P, Muggeo M, Cattin L, Arcangeli A, Pozzilli P, Provenzano V, et al. Incidence of severe nocturnal hypoglycemia in patients with type 1 diabetes treated with insulin lispro or regular human insulin in addition to basal insulin glargine. Nutr Metab Cardiovasc Dis 2010, 20:519-526.
19. Johansen OE, Vanberg PJ, Kilhovd BK, Jorgensen AP Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia. Vase Health Risk Manag 2009, 5:121-128.
20. Danne T, Datz N, Endahl L, Haahr H, Nestoris C, Westergaard L, et al. Insulin detemir is characterized by a more reproducible pharmacokinetic profile than insulin glargine in children and adolescents with type 1 diabetes: results from a randomized, double-blind, controlled trial. Pediatr Diabetes 2008, 9:554-560.
21. Crotty S, Reynolds SL The new insulins. Pediatr Emerg Care 2007, 23:903-905.
22. Mortensen H, Kocova M, Teng LY, Keiding J, Bruckner I, Philotheou A Biphasic insulin aspart vs. human insulin in adolescents with type 1 diabetes on multiple daily insulin injections. Pediatr Diabetes 2006, 7:4-10.
23. Mortensen HB, Robertson KJ, Aanstoot HJ, Danne T, Holl RW, Hougaard P, et al. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes. DiabetMed 1998, 15:752-759.
24. Kaufman FR Intensive management of type 1 diabetes in young children. Lancet 2005, 365:737-738.
25. Hanas R, Adolfsson P Insulin pumps in pediatrie routine care improve long-term metabolic control without increasing the risk of hypoglycemia. Pediatr Diabetes 2006, 7:25-31.
26. Burdick P, Cooper S, Horner B, Cobry E, McFann K, Chase HP Use of a subcutaneous injection port to improve glycemic control in children with type 1 diabetes. Pediatr Diabetes 2009, 10:116-119.
27. Eugster EA, Francis G, Lawson Wilkins Drug and Therapeutics Committee Position Statement: continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics 2006, 118:e1244-e1249.